A new study led by investigators from Mass General Cancer Center reveals the effectiveness of more scalable ways of delivering palliative care to patients with advanced lung cancer.
Trial reveals benefits of 'stepped' palliative care for patients with advanced lung cancer retrieved 3 June 2024 from https://medicalxpress.com/news/2024-06-trial-reveals-benefits-palliative-patients.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Mar 3, 2021Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Belfast mum diagnosed with cancer after noticing 'odd-looking spot'Lyn's skin cancer was detected by the Action Cancer's skin cancer detection service
Read more »
Uber, Lyft argue they're not transportation providers as Mass. trial startsUber and Lyft kicked off a defense of their worker classification status quo in Massachusetts Monday by pitching themselves as technology companies that…
Read more »
Experimental treatment for metastatic pancreatic cancer shows promise in phase 2 clinical trialClinicians at Georgetown University's Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a phase 2 clinical trial of the experimental drug BXCL701 in combination with the immunotherapy drug pembrolizumab (Keytruda).
Read more »
Immunotherapy significantly increases the number of patients free from bowel cancer: Clinical trialAn immunotherapy drug given before surgery instead of chemotherapy meant that over ten times more patients with a certain genetic profile were cancer-free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.
Read more »
Experimental therapy shows promise in pancreatic cancer clinical trialClinicians at Georgetown University's Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a Phase II clinical trial of the experimental drug BXCL701 in combination with the immunotherapy drug pembrolizumab (Keytruda).
Read more »
Trial shows mistletoe extract does not increase survival in advanced pancreatic cancerThe MISTRAL study, involving 290 patients with advanced pancreatic cancer, has investigated whether treatment with mistletoe extract (ME) in addition to standard treatment could help patients live longer. The result is that the treatment did not make any difference compared to placebo in how long the patients lived.
Read more »